[Innovations in surgery-How can new technologies be safely implemented in the clinical practice?]

Innovationen in der Chirurgie – wie können neue Technologien sicher in die Klinik eingeführt werden?
Ethics Evaluation Evidence Long-term results Patient safety

Journal

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
ISSN: 1433-0385
Titre abrégé: Chirurg
Pays: Germany
ID NLM: 16140410R

Informations de publication

Date de publication:
Jul 2020
Historique:
pubmed: 6 6 2020
medline: 18 9 2020
entrez: 6 6 2020
Statut: ppublish

Résumé

Modern surgery is currently undergoing a significant change in the sense of the introduction of modern technologies and innovative techniques. Robotic-assisted surgery and modern techniques of visualization confront surgery with unprecedented challenges with respect to possible and meaningful areas of application for these innovations. If an innovation is not to remain only an interesting singularity as proof of feasibility and a sign of unchecked progress but is to have a fixed place within the framework of standardized treatment processes, firm regulations are required which flank the path from innovation to introduction into clinical practice. This overview article critically examines the deficits of the currently practiced models of introducing new technologies into the clinical practice and discusses new aspects that can improve the introduction of innovations with particular respect to patient safety.

Identifiants

pubmed: 32500214
doi: 10.1007/s00104-020-01195-7
pii: 10.1007/s00104-020-01195-7
doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

553-560

Auteurs

M Bahra (M)

Chirurgische Klinik, Campus Charité Mitte/Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland. marcus.bahra@charite.de.

J Pratschke (J)

Chirurgische Klinik, Charité - Universitätsmedizin Berlin, Berlin, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH